| Literature DB >> 31592229 |
Xiaomin Zhao1, Xuelian Ma1, Jianxiong Guo1, Mi Mi1, Kaili Wang1, Chuyi Zhang1, Xiaoyi Tang1, Lingling Chang1, Yong Huang1, Dewen Tong1.
Abstract
Transmissible gastroenteritis (TGE) is a contagious and infectious disease that is characterized by severe vomiting and diarrhea of swine , especially piglet, and caused by transmissible gastroenteritis coronavirus (TGEV) . TGEV infection provokes mitochondrial damage of porcine intestinal epthelial cell (IPEC), which is responsible for inflammation and cell death. In our previous study, we have demonstrated that circular RNA circEZH2 was down-regulated during TGEV infection and promoted the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) via targeting miR-22 in porcine intestinal epithelial cell line (IPEC-J2). Activation of NF-κB is an important factor for mitochondrial damage. Mitochondrial permeability transition pore (mPTP) opening is a key reason for mitochondrial damage. So, we speculate that circEZH2 may regulate TGEV-induced mPTP opening via NF-kB pathway. In the present study, we found that mPTP opening of IPEC-J2 was occured during TGEV infection and suppressed by circEZH2 via attaching miR-22. Hexokinase 2 (HK2) and interleukin 6 (IL-6) were identified as the targets of miR-22. Silencing HK2 enhanced TGEV-induced mPTP opening, while no effect on NF-κB pathway. Silencing IL-6 promoted TGEV-induced mPTP opening and inhibited NF-κB pathway. Inhibitor of NF-κB increased TGEV-induced mPTP opening. The data revealed that TGEV-induced mPTP opening was regulated via two pathways: circEZH2/miR-22/HK2 axis and circEZH2/miR-22/IL-6/NF-κB axis. © The author(s).Entities:
Keywords: NF-κB; circular RNA; microRNA; mitochondrial permeability transition pore; transmissible gastroenteritis coronavirus virus
Mesh:
Substances:
Year: 2019 PMID: 31592229 PMCID: PMC6775298 DOI: 10.7150/ijbs.36532
Source DB: PubMed Journal: Int J Biol Sci ISSN: 1449-2288 Impact factor: 6.580
Figure 1TGEV infection resulted in mitochondrial damage and mPTP opening. (A) and (B) Histological changes of piglet jejunum infected with TGEV. (C) and (D) Ultrastructure changes of mitochondria in jejunum IPEC of piglet in response to TGEV infection. (E) and (F) Ultrastructure changes of mitochondria in IPEC-J2 in response to TGEV infection. Black arrows indicate mitochondrion. Black triangles indicate viral particle. (G) and (H) The degree of mPTP opening of IPEC-J2 infected with TGEV. The fluorescence was measured via FCM and quantified with Fluorescence Activated Cell Sorting (FACS). ** p < 0.01.
Figure 2circEZH2 localized at both nucleus and cytoplasm, and suppressed TGEV-induced mPTP opening. (A) The genomic loci of circEZH2 and the Sanger sequence of backsplice site of circEZH2. Arrows represent divergent primers binding to the genome region of circEZH2. (B) qRT-PCR analysis of β-actin and circEZH2 after Rnase R treatment. (C) qRT-PCR analysis of circEZH2 in cytoplasm and nuclear. mRNA level ofβ-actin in cytoplasm and U6 level in nuclear fraction were respectively referred as quality controls of cytoplasm and nuclear fractions. (D) circEZH2 was localized at both nucleus and cytoplasm in IPEC-J2 and jejunum IPEC of piglet. (E) Fold change of circEZH2 level in IPEC-J2 in response to TGEV infection. (F) Fold change of circEZH2 level in jejunum IPEC of piglet in response to TGEV infection. (G) Overexpression effect of pcircRNA-circEZH2. (H) Silencing effect of si-circEZH2. (I) The effect of circEZH2 on TGEV-induced mPTP opening in IPEC-J2. (J) and (K) Quantification of mPTP opening level of Figure 2I. ** p < 0.01.
Figure 3miR-22 was localized at cytoplasm and promoted mPTP opening. (A) Localization of miR-22 in IPEC-J2 and jejunum IPEC of piglet. (B) Fold change of miR-22 in IPEC-J2 in response to TGEV infection. (C) Fold change of miR-22 in jejunum IPEC of piglet in response to TGEV infection. (D) Overexpression effect of miR-22 mimics. (E) Silencing effect of miR-22 inhibitor. (F) The effect of miR-22 on TGEV-induced mPTP opening in IPEC-J2. (G) and (H) Quantification of mPTP opening level of Figure 3F. * p < 0.05 and ** p < 0.01 in comparison with the control.
Figure 4circEZH2 functions as sponge of miR-22. (A) Colocalization between miR-22 and circEZH2 in IPEC-J2 infected with TGEV. circEZH2 is shown in red. miR-22 is shown in green. Nucleus is shown in blue. (B) The combined effect of circEZH2 and miR-22 on TGEV-induced mPTP opening in IPEC-J2. (C) Quantification of mPTP opening level of Figure 4B using FACS. (D) The effect of TGEV on p-p65. (E) The effect of miR-22 on p-p65. (F) The combined effect of circEZH2 and miR-22 on p-p65. ** p < 0.01 in comparison with the control.
Figure 5Correlation analysis between miR-22 target genes and identified mRNAs. (A) Venn diagram showed the intersection of mRNAs among the four samples. (B) Venn diagram showed the intersection between miR-22 targets and overlapped mRNAs. (C) GO enrichment analysis of miR-22 target genes. (D) The interaction network of miR-22 and its target genes. Red circles indicate target genes of miR-22 localized at mitochondria or participated in the immune system process. (E) The binding ability of miR-22 to 3' UTRs of 16 potential target genes. (F) Schematic overview of mutation of swine HK2 3' UTR sequence. The upper sequence is the binding site of miR-22 in 3' UTR of swine HK2. The middle is the sequence of mature miR-22. The lower sequence is the mutated binding site sequence of miR-22 of HK2 3' UTR. (G) and (H) The relative luciferase activities of psi-HK2-WT and psi-HK2-Mut mediated by miR-22 mimics and miR-22 inhibitor. (I) The relative mRNA level of HK2 in IPEC-J2 treated with miR-22 mimics and miR-22 inhibitor. (J) The effect of miR-22 on expression of HK2. * p < 0.05 and ** p < 0.01 in comparison with the control.
Figure 6The effects of HK2 on mPTP opening and NF-κB pathway. (A) Network node represents protein. Colored nodes represent the query proteins and the first shell of interactors. White nodes represent the second shell of interactions. Small nodes are the proteins with unknown 3D structure. Large nodes are the proteins with known or predicted 3D structure. Lines represent protein-protein interactions. Light blue line represents from curated databases. Purple line represents experimentally determined. Green line represents gene neighborhood. Red line represents gene fusions. Navy blue line represents gene co-occurrence. Yellow represents textmining. Black line represents co-expression. Grey line represents protein homology. (B) and (C) The silencing effect of si-HK2. (D) The effect of si-HK2 on TGEV-induced mPTP opening. (E) Quantification of mPTP opening level of Figure 6D. (F) The effect of siHK2 on p-p65. ** p < 0.01 in comparison with the control.
Figure 7miR-22 promoted TGEV-induced mPTP opening through suppressing NF-κB pathway and targeting IL-6. (A) Schematic overview of mutation of swine IL-6 3' UTR sequence. The upper sequence is the binding site of miR-22 in 3' UTR of swine IL-6. The middle is the sequence of mature miR-22. The lower sequence is the mutated sequence of IL-6 3' UTR. (B) and (C) The relative luciferase activities of psi-IL-6-WT and psi-IL-6-Mut mediated by miR-22 mimics and miR-22 inhibitor. (D) The relative mRNA level of IL-6 in IPEC-J2 treated with miR-22 mimics and miR-22 inhibitor. * p < 0.05 in comparison with the control. ** p < 0.01 in comparison with the control. (E) Silencing effect of si-IL-6. (F) The effect of si-IL-6 on p-p65. (G) The combined effects of miR-22 inhibitor and si-IL-6 on p-p65. (H) The effect of si-IL-6 on TGEV-induced mPTP opening. (I) Quantification of mPTP opening level of Figure 7H. (J) The effect of BAY 11-7082 (NF-κB inhibitor s) on p-p65. (K) The effect of BAY 11-7082 on TGEV-induced mPTP opening. (L) Quantification of mPTP opening level of Figure 7K. * p< 0.05 in comparison with the control. ** p < 0.01 in comparison with the control.